Preparation of lemongrass essential oil nanoemulsion reveals antimicrobial and antioxidant properties, indicating its potential applications.
Although citrus essential oils, including lemongrass essential oil, have antibacterial, anti-biofilm, and antioxidant properties, their biological instability and poor water solubility render them unsuitable for industrial usage. Thus, this study aimed to prepare both lemongrass essential oil emulsion (LEO-E) and lemongrass essential oil nanoemulsion (LEO-NE), and evaluate their different bioactivities. Characterization by gas chromatography-mass spectroscopy (GC-MS) and evaluation of antimicrobial, antibiofilm, antioxidant, and anticancer activities were carried out. GC-MS results illustrated that D-limonene compound is the dominant among other compounds in LEO. According to transmission electron microscopy and dynamic light scattering, LEO-NE appeared as spherical-shaped droplets with a constant size spanning from 29.1 to 37.4 nm with a polydispersity index value of 0.163. Antimicrobial results showed that LEO-NE exhibited promising antimicrobial activity against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Austromerope brasiliensis with inhibition zones of 25.33 ± 1.1, 26.5 ± 0.5, 22 ± 1, 24.33 ± 0.5, 28.6 ± 1, and 27.97 ± 0.9 mm, respectively. Moreover, LEO-NE showed considerable antiـbiofilm efficacy toward S. aureus and P. aeruginosa with inhibition percentages at 1/2 of MIC of 98.92 and 92.62%, respectively. Furthermore, LEO-NE exhibited antioxidant activity using the 2,2-diphenyl-1-picrylhydrazyl method with 88.5% at 100 µg/mL concentration. In addition, LEO-NE displayed potential anticancer activity toward the human prostate cancer cell line (PC3) and human liver cancer cell line (Hep-G2), where IC50 values were 170.09 and 105.06%, respectively. In conclusion, the prepared LEO-NE in the current study had antimicrobial, antibiofilm, antioxidant, and anticancer activities, which can be used in the medical and pharmaceutical fields.
No takes yet. Share an insight, caveat, or question.
Selim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: